Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_assertion type Assertion NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_head.
- NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_assertion description "[Our in vitro data suggest that reagents directed against LRP/LR or LRP mRNA such as antibodies, polysulfated glycans, or small interfering RNAs, previously shown to encompass an anti-prion activity by blocking or downregulating the prion receptor LRP/LR, might also be potential cancer therapeutics blocking metastasis by interfering with the LRP/LR-laminin interaction in neoplastic tissues.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_provenance.
- NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_assertion evidence source_evidence_literature NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_provenance.
- NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_assertion SIO_000772 18387633 NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_provenance.
- NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_assertion wasDerivedFrom befree-20150227 NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_provenance.
- NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_assertion wasGeneratedBy ECO_0000203 NP660977.RAj7v8hgvmCqpd1LHm3LNo0WLCkKyuwYxDlfm2j2qRa0w130_provenance.